Global EditionASIA 中文雙語(yǔ)Fran?ais
China
Home / China / Health

Chinese researchers make big progress in weight-loss drug research

Xinhua | Updated: 2025-05-30 09:53
Share
Share - WeChat

BEIJING -- Chinese researchers have made big progress in obesity treatment drug research, with the home-grown Mazdutide showing impressive weight-loss effects as well as benefits for metabolic health.

Recently featured in the world-renowned New England Journal of Medicine, the Phase III clinical trial results showed Mazdutide not only demonstrated significant weight-loss results but also offered additional benefits, including reductions in waist circumference, blood pressure, blood lipids and uric acid levels, said Ji Linong, lead researcher and director of the Department of Endocrinology at Peking University People's Hospital.

This milestone places the clinical research of China's independently developed weight-loss drug among the world's leading efforts, said Xiao Ruiping, deputy editor-in-chief of the prestigious international medical journal.

Curbing overweight and obesity is a daunting challenge around the world. Projections indicate that, by 2050, more than half the adult population worldwide will be living with overweight and obesity, according to the journal.

In China, the number of people with overweight and obesity has risen sharply over the past four decades, significantly increasing the risk of noncommunicable diseases such as diabetes, cardiovascular disease, cancer, and premature death.

In response to global health needs, multiple pharmaceutical companies both in China and abroad have stepped up efforts to develop new weight-loss drugs.

In a guideline for the diagnosis and treatment of obesity released by China's national health authority in 2024, medication was listed among the recommended approaches. To date, China has approved five weight-loss medications, with Semaglutide and Orlistat currently available on the domestic market.

Although medication is a proven stepping stone of progress regarding therapies for obesity, it is only one part of the expansive public health toolbox to curb obesity in China.

In 2008, China designated Aug. 8 as its National Fitness Day, and the growing public awareness of health has resulted in a boom in both the fitness and light food industries.

A nationwide campaign to combat obesity is well underway, with weight management clinics being established in hospitals across the country, healthy dietary guidelines released by the national nutrition authority, and primary and secondary schools in many regions implementing the "one physical education class per day" policy.

Despite the effectiveness of weight-loss drugs, experts caution that they are not a panacea, emphasizing that a combination of medication and lifestyle interventions is more effective than either approach alone.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
 
主站蜘蛛池模板: 国产精品久久久久久久久久免费 | 欧美亚洲一区二区三区四| 五月婷婷中文字幕| 男女一进一出抽搐免费视频| 欧美另类xxxx图片| 花季传媒下载免费安装app| 精品国产精品久久一区免费式| 理论片高清免费理论片| 欧美aa在线观看| 拍拍拍无挡无遮10000| 夜色私人影院永久入口| 国产特级毛片AAAAAA| 国产SUV精品一区二区88L| 亚洲黄在线观看| 久久精品无码一区二区三区| 亚洲www视频| jizzjizz护士| 被农民工玩酥了的张小婷| 国产精选之刘婷野战| 美女奶口隐私免费视频网站| 波多野结衣一区二区三区在线观看 | 国产亚洲欧美另类专区| 国产97人人超碰caoprom| 免费一看一级毛片人| 亚洲人成色77777在线观看| 丰满人妻一区二区三区视频53 | 人妻精品久久久久中文字幕一冢本 | 波多野结衣办公室| 最近手机版免费中文字幕| 成人欧美一区二区三区黑人| 国产高清自产拍av在线| 国产在线h视频| 人妻少妇边接电话边娇喘| 亚洲AV无码潮喷在线观看| 亚洲乱码一区二区三区在线观看| 中文字幕精品在线视频| 99re热这里只有精品| 韩国爱情电影妈妈的朋友| 用我的手指搅乱我吧第五集| 最近最新的免费中文字幕| 很污的视频网站|